Claiming They Have Not Heard Of Him

- Dr. Xu filed a lawsuit against the Assembly on December 4, 2012, which is believed to be the first lawsuit ever brought against the Nobel Academy

LOS ANGELES, Dec. 11, 2012 (ANTARA/PRNewswire) -- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist, addresses The Nobel Assembly at Karolinska Institutet's initial statement regarding his lawsuit filing last week against the Academy citing Libel and unfair competition.

The Assembly provided a statement on their site: http://www.nobelprizemedicine.org/?p=3226 whereby they implied they have not heard of Dr. Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist. The Nobel Assembly's lack of acknowledgment is difficult to fathom considering the fact that Dr. Xu has a lifetime achievement in in situ regeneration research and is known worldwide as a pioneer in the field of regenerative medicine.

Furthermore, Dr. Xu was interviewed exclusively in 2003 by Sweden's Ministry of Education and Science and Sweden's national television SVT covering the topic of human body regeneration science. It is also unlikely that The Nobel Assembly did not check US patents before they published statements on the Nobel Prize Awards.

Dr. Xu states, "I am not interested in who is awarded the Nobel Prize and I do not devalue the award. I am concerned about the statements made by the Nobel Assembly. I seek clarification regarding the issue of 'pluripotency by reprogramming' as it has been incorrectly stated and this can impact the safety of human life. I hope the Nobel Assembly can clarify what its 'pluripotency' means, is it completely conforming with the nature of human life? Or, is it the pluripotency of human cancer cells."

The Plaintiff, Dr. Xu is represented by the Ardent Law Group in California (case number 30-2012-00615804). For additional information, please contact Jane Westgate 336.608.4439, or Cheryl Riley 703.683.1798.

Editor: PR Wire
Copyright © ANTARA 2012